Speech-Language Pathologists in Bedminster, NJ Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Mrs. Joanna Marie Guglani, M.A., CCC-SLP/LIC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 134 Autumn Ridge Rd, Bedminster, NJ 07921 Phone: 315-945-4226

Caitlin Greene Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 High Pond Ln, Bedminster, NJ 07921 Phone: 973-229-1608

Jillian Michelle Yospin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 32 Pine Ct, Bedminster, NJ 07921 Phone: 201-424-1346

News Archive

Community-wide intervention reduces obesity risk factors in preschoolers from low-income families

Preschoolers from low-income families living in cities that took part in a two-year community-wide intervention to foster healthy eating and lifestyle habits consumed fewer sugary drinks, got more sleep, and showed improvement in weight, according to a study led by a researcher at NewYork-Presbyterian/Columbia University Medical Center.

Mutations in gene protecting body leads to development of cancer

An important gene that normally protects the body against cancer can itself cause a variety of cancers depending on the specific mutation that damages it, according to a new study by investigators at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

Study assesses impact of social needs on African American cancer survivors

Social needs-such as food and economic insecurity, poor housing and neighborhood conditions, and lack of access to transportation-were common in a group of African American cancer survivors in Detroit, and they were associated with lower health-related quality of life (HRQOL).

Researchers study safety of transendocardial stem cell injection in patients with ischemic cardiomyopathy

Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection with autologous mesenchymal stem cells and bone marrow mononuclear cells in patients with ischemic cardiomyopathy.

Read more Medical News

› Verified 2 days ago